

VCBeat Health Contact Us

China Healthcare Select

Vertical Industries 

Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory

Home Bio-Thera Receives NMPA Approval for BAT2206 (Ustekinumab Biosimilar)

Bio-Thera Receives NMPA Approval for BAT2206 (Ustekinumab Biosimilar)

May 21, 2026 17:34 CST Updated 18:00

Share:

Bio-Thera

Innovative Drug Developer

vcbeatglobal@vcbeat.net 

SERVICES

Partnership Development Market Entry Advisory Ecosystem Engagement Advisory

COMPANY

About VCBeat Why VCBeat Contact Us

CHANNELS

China Healthcare Select Insights MNC China Lens Events VB100 GMPC

MORE

PRIVACY VCBEAT CHINA

© 2025 VCBeat. All rights reserved.